Chiisanogenin Targets MLKL to Restore Autophagy and Suppress Pyroptosis in Renal Ischemia-Reperfusion Injury
Abstract
models confirm that chiisanogenin attenuates IRI-induced acute damage and retards the AKI-to-CKD fibrotic transition. These findings highlight chiisanogenin as a promising therapeutic candidate for treating ischemic renal injury.
Fields of Study & Subjects
Inflammasome and immune disorders
Autophagy in Disease and Therapy
Gout
Hyperuricemia
Uric Acid
Publication details
- Journal / source
- Journal of Agricultural and Food Chemistry
- Publisher
- American Chemical Society (ACS)
- Volume
- 74
- Issue
- 22
- Pages
- 17099–17128
- Publication date
- 2 June 2026
- Language
- EN